✦ LIBER ✦

A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy

✍ Scribed by Sang Joon Shin, Minkyu Jung, Hei-Cheul Jeung, Hye Ryun Kim, Sun Young Rha, Jae Kyung Roh, Hyun Cheol Chung, Joong Bae Ahn

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II open-label randomized multice

✍ Lee, Jeeyun; Shin, Sang Joon; Chung, Ik Joo; Kim, Tae Won; Chun, Hoo-Geun; Shin, 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 313 KB

A phase I and pharmacokinetic study of O

✍ A. R. Clamp; P. Schöffski; J. W. Valle; R. H. Wilson; S. Marreaud; A.-S. Govaert 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 315 KB

Phase I and pharmacokinetic study of TSU

✍ Yutaka Ueda; Tatsu Shimoyama; Haruyasu Murakami; Noboru Yamamoto; Yasuhide Yamad 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 472 KB

A multicenter phase II study of TSU-68,

✍ Suzuki, Yasuhiro; Saeki, Toshiaki; Aogi, Kenjiro; Toi, Masakazu; Fujii, Hirofumi 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 259 KB

Phase I clinical and pharmacokinetic/pha

✍ Park, Sook Ryun; Hong, Yong Sang; Lim, Hyeong-Seok; Seong, Moon-Woo; Kong, Sun-Y 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 747 KB

704 POSTER A phase I dose escalation and

✍ E. Raymond; F. Goldwasser; G. Bousquet; C. Le Tourneau; S. Faivre; H. de-Montser 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB